10.09
price down icon0.49%   -0.05
after-market Dopo l'orario di chiusura: 10.09
loading

Iteos Therapeutics Inc Borsa (ITOS) Ultime notizie

pulisher
Aug 02, 2025

What is the dividend policy of iTeos Therapeutics Inc. stockAchieve consistent double-digit returns - jammulinksnews.com

Aug 02, 2025
pulisher
Aug 02, 2025

How volatile is iTeos Therapeutics Inc. stock compared to the marketCapitalize on emerging investment opportunities - jammulinksnews.com

Aug 02, 2025
pulisher
Aug 01, 2025

What makes iTeos Therapeutics Inc. stock price move sharplyMarket Forecast Report For 2025 - jammulinksnews.com

Aug 01, 2025
pulisher
Aug 01, 2025

Price momentum metrics for iTeos Therapeutics Inc. explainedDaily Technical Forecast for Quick Gains - Newser

Aug 01, 2025
pulisher
Jul 31, 2025

What are the technical indicators suggesting about iTeos Therapeutics Inc.Wealth Building Planner With Proven Results - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 31, 2025

Halper Sadeh Investigates iTeos Therapeutics, Veritex Holdings Merger Deals. - AInvest

Jul 31, 2025
pulisher
Jul 30, 2025

Why iTeos Therapeutics Inc. stock attracts strong analyst attentionTrade Timing Strategy With Technical Data Explained - metal.it

Jul 30, 2025
pulisher
Jul 30, 2025

Investigations into OLO, VBTX, ITOS, and WNS Shareholder Rights - AInvest

Jul 30, 2025
pulisher
Jul 30, 2025

Reddit Investors Lose Big, Now Have Opportunity to Lead Fraud Lawsuit - AInvest

Jul 30, 2025
pulisher
Jul 30, 2025

iTeos Therapeutics acquisition by Concentra Biosciences raises fiduciary duty concerns. - AInvest

Jul 30, 2025
pulisher
Jul 30, 2025

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire

Jul 30, 2025
pulisher
Jul 30, 2025

Visual trend scoring systems applied to iTeos Therapeutics Inc.Alpha Driven Watchlist With Alerts Published - metal.it

Jul 30, 2025
pulisher
Jul 29, 2025

What catalysts could drive iTeos Therapeutics Inc. stock higher in 2025Wealth Building Planner With Proven Results - jammulinksnews.com

Jul 29, 2025
pulisher
Jul 29, 2025

iTeos Therapeutics Inc. Added to High Probability Setup ListTriple Return Setup With Risk Control Explained - metal.it

Jul 29, 2025
pulisher
Jul 28, 2025

These 10 Stocks are Winning Big - Insider Monkey

Jul 28, 2025
pulisher
Jul 28, 2025

Is iTeos Therapeutics Inc. stock overvalued or undervaluedSuperior returns - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Is iTeos Therapeutics Inc. stock poised for growthReliable Investment Entry Signals Confirmed by Charts - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

Using data tools to time your iTeos Therapeutics Inc. exitFree Early Entry Picks Before News Breakout - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

Can momentum traders help lift iTeos Therapeutics Inc.Trade Setup Builder with Custom Alerts - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

Price momentum metrics for iTeos Therapeutics Inc. explained Long-Term Safety Investment Analysis Report - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

What is iTeos Therapeutics Inc. company’s growth strategyExponential return rates - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

How strong is iTeos Therapeutics Inc. company’s balance sheetInvest smarter with expert trading signals - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

Is iTeos Therapeutics Inc. a growth stock or a value stockGet timely alerts on market opportunities - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Published on: 2025-07-27 21:40:11 - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How Efficient Is iTeos Therapeutics Inc. at Controlling Operating CostsFree Deep Market Trend Analysis - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

Key External Factors That Drive iTeos Therapeutics Inc. Stock Price MovementsDaily Breakout Picks - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

Will iTeos Therapeutics Inc. Stock Benefit from AI and Green Energy TrendsCapital Growth Picks - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

How iTeos Therapeutics Inc. stock performs during market volatilityFree Stock Selection with 300% Return - Newser

Jul 27, 2025
pulisher
Jul 26, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITOS, CIO, SNV on Behalf of Shareholders - GlobeNewswire Inc.

Jul 26, 2025
pulisher
Jul 26, 2025

Wedbush Research Analysts Cut Earnings Estimates for ITOS - Defense World

Jul 26, 2025
pulisher
Jul 25, 2025

iTeos Therapeutics Inc. Stock Analysis and ForecastRecord-breaking capital gains - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Will iTeos Therapeutics Inc. stock split in the near futureHigh-yield investments - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

What drives iTeos Therapeutics Inc. stock priceExceptional growth trajectory - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Q2 EPS Estimate for iTeos Therapeutics Lowered by Analyst - Defense World

Jul 25, 2025
pulisher
Jul 24, 2025

SHAREHOLDER ALERT: Morris Kandinov Investigating AVDX, - GlobeNewswire

Jul 24, 2025
pulisher
Jul 24, 2025

What analysts say about iTeos Therapeutics Inc. stockFree Stock Market Knowledge Sharing - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

Is iTeos Therapeutics Inc. stock overhyped or has real potentialFree Predictions - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

Leerink Partners Maintains Hold Rating on iTeos Therapeutics with $10 Price Target - AInvest

Jul 23, 2025
pulisher
Jul 22, 2025

Assessing the Fairness of iTeos Therapeutics' $10.047-per-Share Acquisition Offer: A Valuation Deep Dive - AInvest

Jul 22, 2025
$75.59
price up icon 0.93%
$37.11
price up icon 0.84%
$108.69
price up icon 1.31%
$27.07
price up icon 2.65%
$107.34
price down icon 0.15%
biotechnology ONC
$299.01
price down icon 0.70%
Capitalizzazione:     |  Volume (24 ore):